In dilated cardiomyopathy, short-term administration of L-thyroxine (100 micrograms/ day) improves cardiac and exercise performance without changing the heart's adrenergic sensitivity. The aim of this study was to test the medium-term (3 months) efficacy of L-thyroxine (10 patients) compared with placebo (10 patients) and to find out whether later effects are obtainable.

Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy / P. Moruzzi, E. Doria, P. G. Agostoni. - In: THE AMERICAN JOURNAL OF MEDICINE. - ISSN 0002-9343. - 101:5(1996 Nov), pp. 461-7-467.

Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy

P. Moruzzi
Primo
;
P. G. Agostoni
Ultimo
1996

Abstract

In dilated cardiomyopathy, short-term administration of L-thyroxine (100 micrograms/ day) improves cardiac and exercise performance without changing the heart's adrenergic sensitivity. The aim of this study was to test the medium-term (3 months) efficacy of L-thyroxine (10 patients) compared with placebo (10 patients) and to find out whether later effects are obtainable.
Electrocardiography, Ambulatory; Humans; Cardiomyopathy, Dilated; Echocardiography; Aged; Hemodynamics; Hormones; Exercise Test; Oxygen Consumption; Treatment Outcome; Thyroxine; Middle Aged; Time Factors; Female; Male
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/188697
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 117
  • ???jsp.display-item.citation.isi??? 102
social impact